• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ADAC revenues boom in third quarter

Article

ADAC Laboratories saw revenues and net income rise sharply forits third quarter (end-June). The Milpitas, CA, vendor attributedthe growth to several factors, including the addition of revenuesfrom information systems vendor Community Health Computing,

ADAC Laboratories saw revenues and net income rise sharply forits third quarter (end-June). The Milpitas, CA, vendor attributedthe growth to several factors, including the addition of revenuesfrom information systems vendor Community Health Computing, acquiredlast year, and increased sales of both gamma cameras and informationsystems.

For the quarter, ADAC posted sales of $62.4 million, up 37%from revenues of $45.6 million in the third quarter of 1995. ADACCFO Andre Simone said much of the growth was due to higher gammacamera sales related to the company's molecular coincidence detection(MCD) high-energy imaging technique. Gamma camera purchasers wantto acquire ADAC cameras so they can add MCD when it begins shipping,Simone said. ADAC plans to begin shipping the technology on completionof clinical trials designed to validate the technique.

ADAC's revenue increase was also due to the addition of revenuesfrom CHC, which were not included in ADAC's third-quarter resultslast year. ADAC has been successful in growing sales in that businessas well, Simone said.

Net income was another bright spot for ADAC. The company hadnet income of $4.4 million for the quarter, compared with $3.1million in the same period last year.

In other news, ADAC announced that it has been awarded a two-yearcontract as a preferred provider for the Columbia/HCA hospitalchain, joining GE Medical Systems as the only other preferredvendor for gamma cameras.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.